Tetrahydrocannabiphorol (THC-P) stands out as a potent cannabinoid, exhibiting stronger psychoactive effects than the commonly known Delta-9 THC. Its high affinity for CB1 and CB2 receptors in the endocannabinoid system suggests significant potential for intense euphoria and therapeutic benefits, particularly in pain relief and insomnia management. This makes the cannabinoid a promising candidate for medical cannabis users with high THC tolerance or those in search of more potent effects.

Why THC-P?

The potency of the cannabinoid necessitates careful consideration of dosage to manage its powerful psychoactive impact. Emerging products like vapes and edibles target a specific consumer base seeking the next level of cannabinoid experiences, but it’s always important to start small and work your way up to find the proper dosage.